サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：カテコールアミン市場- タイプ別、投与経路別、適応症別、流通チャネル別、世界予測、2023年～2032年
市場調査レポート
商品コード
1370633

カテコールアミン市場- タイプ別、投与経路別、適応症別、流通チャネル別、世界予測、2023年～2032年

Catecholamines Market - By Type (Dopamine, Norepinephrine, Epinephrine), Route of Administration (Intravenous, Inhalation), Indication (Anaphylaxis, Cardiac Arrest, Acute Asthma), Distribution Channel (Hospital Pharmacy), Global Forecast 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 180 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
カテコールアミン市場- タイプ別、投与経路別、適応症別、流通チャネル別、世界予測、2023年～2032年
出版日: 2023年08月30日
発行: Global Market Insights Inc.
ページ情報: 英文 180 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

カテコールアミン市場規模は、2023年から2032年にかけてCAGR 6.7%で成長すると推定されます。

これは、革新的な医薬品と治療法の開発のために、大手製薬企業が研究開発投資に注力しているためです。

徐放性製剤や先進的吸入療法を含む新規ドラッグデリバリー・メカニズムの探求は、カテコールアミンの応用範囲を大幅に拡大しています。さらに、精密医療が重視され、特定の患者プロファイルに合わせた標的療法の開発が、より効果的で効率的なカテコールアミン治療の創出を促進しています。この継続的な技術革新が患者の転帰を向上させ、業界全体の拡大にさらに貢献しています。

カテコールアミン産業は、タイプ、投与経路、適応症、流通チャネル、地域に分類されます。

タイプ別では、認知、行動、運動など様々な生理的プロセスにおけるカテコールアミンの応用が増加しているため、2023年から2032年にかけてドーパミンセグメントの市場価値が大きく牽引すると予測されています。パーキンソン病や統合失調症などの神経疾患におけるドーパミンの関与を明らかにするための研究が進行しており、ドーパミンをベースとした薬物療法に対する需要が急増しています。また、ドーパミンを標的とした新規治療薬や革新的なドラッグデリバリー機構の開発を促進するため、製薬企業が研究開発活動を活発化させていることも、同分野の成長に寄与しています。

適応症別では、急性喘息分野が2022年のカテコールアミン市場においてかなりの売上シェアを占め、2032年まで力強い成長を記録すると予測されています。これは、気管支拡張におけるカテコールアミンの用途が増加していることと、急性気管支収縮の管理に有効であることによる。2023年にNCBIが発表した報告書によると、喘息は世界中で約3億人が罹患し、重大な罹患率と死亡率につながっています。そのため、カテコールアミンを主成分とする気管支拡張薬の採用が、特に緊急の場面で急増しており、市場開拓に拍車をかけると思われます。

地域的には、アジア太平洋地域のカテコールアミン産業は、心血管疾患の有病率の増加とヘルスケア支出の増加により、2032年まで大きな成長を示すと考えられています。アジア開発銀行によると、アジア太平洋地域の4人に1人が2050年までに60歳を超えると予想されており、これは寿命の延長と出生率の低下によるものです。また、ヘルスケア・インフラの急速な進歩は、心血管疾患への早期介入の利点に関する意識の高まりに寄与しています。様々な心血管系疾患に罹患しやすい老年人口基盤の拡大は、この地域の市場成長を支えることになります。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 カテコールアミン産業洞察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 慢性疾患の増加
      • 老人人口の増加
      • ドラッグデリバリーの技術進歩
    • 業界の潜在的リスク＆課題
      • 副作用と有害反応
      • 厳しい規制の枠組み
  • 成長可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 カテコールアミン市場：タイプ別、2018年～2032年

  • 主要動向：タイプ別
  • エピネフリン（アドレナリン）
  • ノルエピネフリン（ノルアドレナリン）
  • ドーパミン

第6章 カテコールアミン市場：適応症別、2018年～2032年

  • 主要動向：適応症別
  • アナフィラキシー
  • 心停止
  • ショック
  • 急性喘息
  • 高血圧症
  • その他の適応症

第7章 カテコールアミン市場：投与経路別、2018年～2032年

  • 主要動向：投与経路別
  • 静脈内投与
  • 吸入
  • 経皮
  • その他の投与経路

第8章 カテコールアミン市場：流通チャネル別、2018年～2032年

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 カテコールアミン市場：地域別、2018年～2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第10章 企業プロファイル

  • Pfizer, Inc.
  • Viatris, Inc.
  • Novartis International AG
  • Amneal Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd
  • Baxter International
  • Breckenridge Pharmaceutical, Inc.
  • Lexicare Pharma Pvt. Ltd
  • Midas Pharma GmbH
  • Sun Pharmaceutical Industries Ltd.
図表

Data Tables

  • TABLE 1 Market revenue, by type (2022)
  • TABLE 2 Market revenue, by route of administration (2022)
  • TABLE 3 Market share, by indication (2022)
  • TABLE 4 Market share, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global catecholamines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global catecholamines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 9 Global catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 10 Global catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 11 Global catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 12 Global catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 13 Global catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 14 Global catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 15 Global catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Epinephrine (adrenaline) market size, 2018 - 2022 (USD Million)
  • TABLE 18 Epinephrine (adrenaline) market size, 2023 - 2032 (USD Million)
  • TABLE 19 Norepinephrine (noradrenaline) market size, 2018 - 2022 (USD Million)
  • TABLE 20 Norepinephrine (noradrenaline) market size, 2023 - 2032 (USD Million)
  • TABLE 21 Dopamine market size, 2018 - 2022 (USD Million)
  • TABLE 22 Dopamine market size, 2023 - 2032 (USD Million)
  • TABLE 23 Anaphylaxis market size, 2018 - 2022 (USD Million)
  • TABLE 24 Anaphylaxis market size, 2023 - 2032 (USD Million)
  • TABLE 25 Cardiac arrest market size, 2018 - 2022 (USD Million)
  • TABLE 26 Cardiac arrest market size, 2023 - 2032 (USD Million)
  • TABLE 27 Shock market size, 2018 - 2022 (USD Million)
  • TABLE 28 Shock market size, 2023 - 2032 (USD Million)
  • TABLE 29 Acute asthma market size, 2018 - 2022 (USD Million)
  • TABLE 30 Acute asthma market size, 2023 - 2032 (USD Million)
  • TABLE 31 Hypertension market size, 2018 - 2022 (USD Million)
  • TABLE 32 Hypertension market size, 2023 - 2032 (USD Million)
  • TABLE 33 Other indications market size, 2018 - 2022 (USD Million)
  • TABLE 34 Other indications market size, 2023 - 2032 (USD Million)
  • TABLE 35 Intravenous market size, 2018 - 2022 (USD Million)
  • TABLE 36 Intravenous market size, 2023 - 2032 (USD Million)
  • TABLE 37 Inhalation market size, 2018 - 2022 (USD Million)
  • TABLE 38 Inhalation market size, 2023 - 2032 (USD Million)
  • TABLE 39 Transdermal market size, 2018 - 2022 (USD Million)
  • TABLE 40 Transdermal market size, 2023 - 2032 (USD Million)
  • TABLE 41 Other routes of administration market size, 2018 - 2022 (USD Million)
  • TABLE 42 Other routes of administration market size, 2023 - 2032 (USD Million)
  • TABLE 43 Hospital pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 44 Hospital pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 45 Retail pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 46 Retail pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 47 Online pharmacy market size, 2018 - 2022 (USD Million)
  • TABLE 48 Online pharmacy market size, 2023 - 2032 (USD Million)
  • TABLE 49 North America catecholamines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 50 North America catecholamines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 51 North America catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 52 North America catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 53 North America catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 54 North America catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 55 North America catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 56 North America catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 57 North America catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 58 North America catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 59 U.S. catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 60 U.S. catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 61 U.S. catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 62 U.S. catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 63 U.S. catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 64 U.S. catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 65 U.S. catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 66 U.S. catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 67 Canada catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 68 Canada catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 69 Canada catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 70 Canada catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 71 Canada catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 72 Canada catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 73 Canada catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 74 Canada catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 75 Europe catecholamines Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 76 Europe catecholamines Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 77 Europe catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 78 Europe catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 79 Europe catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 80 Europe catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 81 Europe catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 82 Europe catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 83 Europe catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 84 Europe catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 85 Germany catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 86 Germany catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 87 Germany catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 88 Germany catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 89 Germany catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 90 Germany catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 91 Germany catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 92 Germany catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 93 UK catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 94 UK catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 95 UK catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 96 UK catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 97 UK catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 98 UK catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 99 UK catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 100 UK catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 101 France catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 102 France catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 103 France catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 104 France catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 105 France catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 106 France catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 107 France catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 108 France catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 109 Spain catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 110 Spain catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 111 Spain catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 112 Spain catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 113 Spain catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 114 Spain catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 115 Spain catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 116 Spain catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 117 Italy catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 118 Italy catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 119 Italy catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 120 Italy catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 121 Italy catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 122 Italy catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 123 Italy catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 124 Italy catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 125 Rest of Europe catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 126 Rest of Europe catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 127 Rest of Europe catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 128 Rest of Europe catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 129 Rest of Europe catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 130 Rest of Europe catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 131 Rest of Europe catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 132 Rest of Europe catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 133 Asia Pacific catecholamines Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 134 Asia Pacific catecholamines Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 135 Asia Pacific catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 136 Asia Pacific catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 137 Asia Pacific catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 138 Asia Pacific catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 139 Asia Pacific catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 140 Asia Pacific catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 141 Asia Pacific catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 142 Asia Pacific catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 143 Japan catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 144 Japan catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 145 Japan catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 146 Japan catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 147 Japan catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 148 Japan catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 149 Japan catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 150 Japan catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 151 China catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 152 China catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 153 China catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 154 China catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 155 China catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 156 China catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 157 China catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 158 China catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 159 India catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 160 India catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 161 India catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 162 India catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 163 India catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 164 India catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 165 India catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 166 India catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 167 Australia catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 168 Australia catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 169 Australia catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 170 Australia catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 171 Australia catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 172 Australia catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 173 Australia catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 174 Australia catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 175 Rest of Asia Pacific catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 176 Rest of Asia Pacific catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 177 Rest of Asia Pacific catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 178 Rest of Asia Pacific catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 179 Rest of Asia Pacific catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 180 Rest of Asia Pacific catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 181 Rest of Asia Pacific catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 182 Rest of Asia Pacific catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 183 Latin America catecholamines Market size, by country, 2018 - 2022 (USD Million)
  • TABLE 184 Latin America catecholamines Market size, by country, 2023 - 2032 (USD Million)
  • TABLE 185 Latin America catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 186 Latin America catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 187 Latin America catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 188 Latin America catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 189 Latin America catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 190 Latin America catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 191 Latin America catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 192 Latin America catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 193 Brazil catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 194 Brazil catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 195 Brazil catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 196 Brazil catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 197 Brazil catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 198 Brazil catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 199 Brazil catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 200 Brazil catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 201 Mexico catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 202 Mexico catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 203 Mexico catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 204 Mexico catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 205 Mexico catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 206 Mexico catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 207 Mexico catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 208 Mexico catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 209 Rest of Latin America catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 210 Rest of Latin America catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 211 Rest of Latin America catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 212 Rest of Latin America catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 213 Rest of Latin America catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 214 Rest of Latin America catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 215 Rest of Latin America catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 216 Rest of Latin America catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 217 Middle East & Africa catecholamines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 218 Middle East & Africa catecholamines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 219 Middle East & Africa catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 220 Middle East & Africa catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 221 Middle East & Africa catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 222 Middle East & Africa catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 223 Middle East & Africa catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 224 Middle East & Africa catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 225 Middle East & Africa catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 226 Middle East & Africa catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 227 Saudi Arabia catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 228 Saudi Arabia catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 229 Saudi Arabia catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 230 Saudi Arabia catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 231 Saudi Arabia catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 232 Saudi Arabia catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 233 Saudi Arabia catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 234 Saudi Arabia catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 235 South Africa catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 236 South Africa catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 237 South Africa catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 238 South Africa catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 239 South Africa catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 240 South Africa catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 241 South Africa catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 242 South Africa catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 243 Rest of Middle East and Africa catecholamines market size, by type, 2018 - 2022 (USD Million)
  • TABLE 244 Rest of Middle East and Africa catecholamines market size, by type, 2023 - 2032 (USD Million)
  • TABLE 245 Rest of Middle East and Africa catecholamines market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 246 Rest of Middle East and Africa catecholamines market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 247 Rest of Middle East and Africa catecholamines market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 248 Rest of Middle East and Africa catecholamines market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 249 Rest of Middle East and Africa catecholamines market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 250 Rest of Middle East and Africa catecholamines market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Catecholamines industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by indication
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix
  • FIG 16 Strategic dashboard, 2022
目次
Product Code: 6580

Catecholamines Market size is estimated to grow at 6.7% CAGR from 2023-2032 attributed to the heightened focus on R&D investments by leading pharmaceutical companies for the development of innovative medications and therapies.

The exploration of novel drug delivery mechanisms, including sustained-release formulations and advanced inhalation therapies is significantly expanding the scope of catecholamine applications. Additionally, the emphasis on precision medicine and the development of targeted therapies tailored to specific patient profiles is fostering the creation of more effective and efficient catecholamine treatments. This continuous innovation is making way for enhanced patient outcomes, further contributing to the overall industry expansion.

The catecholamines industry is categorized into type, route of administration, indication, distribution channel, and region.

Based on type, the market value from the dopamine segment is projected to gain significant traction from 2023 to 2032 due to increasing application of catecholamines in various physiological processes, including cognition, behavior, and motor activity. The ongoing research for revealing the implication of dopamine in neurological disorders, such as Parkinson's disease and schizophrenia is surging the demand for dopamine-based medications and therapies. The escalating efforts spurred by pharmaceutical companies to intensify R&D activities for fostering the development of novel dopamine-targeted treatments and innovative drug delivery mechanisms will also contribute to the segment growth.

In terms of indication, the acute asthma segment accounted for considerable revenue share of the catecholamines market in 2022 and is anticipated to record robust growth up to 2032. This is owing to the rising application of catecholamines in bronchodilation and their effectiveness in managing acute bronchoconstriction. According to the reports published by NCBI in 2023, asthma affects about 300 million people worldwide, leading to significant morbidity and death rate. To that end, the escalating adoption of catecholamine-based bronchodilators, especially in emergency settings will add to the market development.

Regionally, the Asia Pacific catecholamines industry is set to exhibit significant growth through 2032 attributed to the increasing prevalence of cardiovascular diseases and rising healthcare expenditure. According to the Asia Development Bank, one in every four persons in Asia and the Pacific will be beyond the age of 60 years by 2050 driven by longer life spans and lower fertility rates. Additionally, the rapid advancements in healthcare infrastructure is contributing to the growing awareness regarding the benefits of early intervention in cardiovascular ailments. The expanding geriatric population base prone to various cardiovascular conditions will thus support the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Catecholamines industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Type trends
    • 2.1.4 Indication trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Distribution channel trends

Chapter 3 Catecholamines Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing geriatric population
      • 3.2.1.3 Technological advancement in drug delivery system
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects and adverse reactions
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By indication
    • 3.3.3 By route of administration
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Catecholamines Market, By Type, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Epinephrine (adrenaline)
  • 5.3 Norepinephrine (noradrenaline)
  • 5.4 Dopamine

Chapter 6 Catecholamines Market, By Indication, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by indication
  • 6.2 Anaphylaxis
  • 6.3 Cardiac arrest
  • 6.4 Shock
  • 6.5 Acute asthma
  • 6.6 Hypertension
  • 6.7 Other indications

Chapter 7 Catecholamines Market, By Route of Administration, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Intravenous
  • 7.3 Inhalation
  • 7.4 Transdermal
  • 7.5 Other routes of administration

Chapter 8 Catecholamines Market, By Distribution Channel, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Catecholamines Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Pfizer, Inc.
  • 10.2 Viatris, Inc.
  • 10.3 Novartis International AG
  • 10.4 Amneal Pharmaceuticals
  • 10.5 Teva Pharmaceutical Industries Ltd
  • 10.6 Baxter International
  • 10.7 Breckenridge Pharmaceutical, Inc.
  • 10.8 Lexicare Pharma Pvt. Ltd
  • 10.9 Midas Pharma GmbH
  • 10.10 Sun Pharmaceutical Industries Ltd.